MMP9 and melanoma: By targeting MMP9, MMP12, MMP14, and MMP16, it is conceivable that Estradiol and Calcitriol could disrupt critical pathways involved in melanoma progression, offering a novel and potentially effective approach for combating this aggressive form of skin cancer.